Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery
Clinical trial NCT04877756 · COMPLETED
Trial details
- NCT number
- NCT04877756
- Sponsor
- Olix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-19
- Primary completion
- 2023-01-11
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.